Which has preferable earnings and valuation, NSPR or OWLT?

InspireMD has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InspireMD $10.84M 3.30 -$19.92M -$0.64 N/A Owlet $105.70M 1.26 -$39.68M -$0.75 N/A

Is NSPR or OWLT more profitable?

Owlet has a net margin of -8.61% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% Owlet -8.61% -601.24% -15.96%

Do analysts prefer NSPR or INGN?

InspireMD presently has a consensus price target of $4.50, indicating a potential upside of 484.42%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InspireMD 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has stronger earnings & valuation, NSPR or INGN?

InspireMD has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InspireMD $10.84M 3.30 -$19.92M -$0.64 N/A Inogen $354.30M 0.38 -$22.75M -$0.90 N/A

Is NSPR or INGN more profitable?

Inogen has a net margin of -6.94% compared to InspireMD's net margin of -413.96%. Inogen's return on equity of -13.17% beat InspireMD's return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% Inogen -6.94% -13.17% -8.36%

Which has higher valuation and earnings, NSPR or APYX?

Apyx Medical has higher revenue and earnings than InspireMD. Apyx Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InspireMD $10.84M 3.30 -$19.92M -$0.64 N/A Apyx Medical $52.84M 2.40 -$11.21M -$0.20 N/A

Is NSPR or APYX more profitable?

Apyx Medical has a net margin of -14.78% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% Apyx Medical -14.78% -76.60% -13.91%

InspireMD (NSPR) Competitors

$0.77 0.00 (0.00%)

Closing price 03:58 PM Eastern

Extended Trading

$0.78 +0.01 (+1.04%)

As of 05:57 PM Eastern

Compare

NSPR vs. KRMD, OWLT, INGN, CNXU, and APYX

Should you buy InspireMD stock or one of its competitors? InspireMD's main competitors and comparable companies include KORU Medical Systems (KRMD), Owlet (OWLT), Inogen (INGN), Conexeu Sciences (CNXU), and Apyx Medical (APYX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does InspireMD compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and InspireMD (NYSE:NSPR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.

KORU Medical Systems has a net margin of -4.03% compared to InspireMD's net margin of -413.96%. KORU Medical Systems' return on equity of -10.63% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
InspireMD	-413.96%	-69.42%	-57.68%

KORU Medical Systems has higher revenue and earnings than InspireMD. KORU Medical Systems is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.57	-$2.64M	-$0.04	N/A
InspireMD	$10.84M	3.30	-$19.92M	-$0.64	N/A

In the previous week, KORU Medical Systems had 3 more articles in the media than InspireMD. MarketBeat recorded 3 mentions for KORU Medical Systems and 0 mentions for InspireMD. KORU Medical Systems' average media sentiment score of 1.90 beat InspireMD's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Overall Sentiment
KORU Medical Systems	Very Positive
InspireMD	Neutral

KORU Medical Systems has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, InspireMD has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 25.0% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

KORU Medical Systems currently has a consensus price target of $7.00, indicating a potential upside of 118.75%. InspireMD has a consensus price target of $4.50, indicating a potential upside of 484.42%. Given InspireMD's stronger consensus rating and higher possible upside, analysts plainly believe InspireMD is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

KORU Medical Systems beats InspireMD on 11 of the 16 factors compared between the two stocks.

How does InspireMD compare to Owlet?

InspireMD (NYSE:NSPR) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation.

InspireMD currently has a consensus target price of $4.50, indicating a potential upside of 484.42%. Owlet has a consensus target price of $15.00, indicating a potential upside of 229.60%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than Owlet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Owlet has a net margin of -8.61% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Owlet	-8.61%	-601.24%	-15.96%

44.8% of InspireMD shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 25.0% of InspireMD shares are held by insiders. Comparatively, 36.2% of Owlet shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

InspireMD has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Owlet has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

InspireMD has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.84M	3.30	-$19.92M	-$0.64	N/A
Owlet	$105.70M	1.26	-$39.68M	-$0.75	N/A

In the previous week, InspireMD's average media sentiment score of 0.00 equaled Owlet'saverage media sentiment score.

Company	Overall Sentiment
InspireMD	Neutral
Owlet	Neutral

Summary

InspireMD beats Owlet on 7 of the 13 factors compared between the two stocks.

How does InspireMD compare to Inogen?

InspireMD (NYSE:NSPR) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

InspireMD has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.84M	3.30	-$19.92M	-$0.64	N/A
Inogen	$354.30M	0.38	-$22.75M	-$0.90	N/A

Inogen has a net margin of -6.94% compared to InspireMD's net margin of -413.96%. Inogen's return on equity of -13.17% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Inogen	-6.94%	-13.17%	-8.36%

44.8% of InspireMD shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 25.0% of InspireMD shares are owned by insiders. Comparatively, 2.5% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

InspireMD has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market. Comparatively, Inogen has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market.

InspireMD presently has a consensus price target of $4.50, indicating a potential upside of 484.42%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Inogen had 2 more articles in the media than InspireMD. MarketBeat recorded 2 mentions for Inogen and 0 mentions for InspireMD. Inogen's average media sentiment score of 1.23 beat InspireMD's score of 0.00 indicating that Inogen is being referred to more favorably in the news media.

Company	Overall Sentiment
InspireMD	Neutral
Inogen	Positive

Summary

Inogen beats InspireMD on 9 of the 17 factors compared between the two stocks.

How does InspireMD compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and InspireMD (NYSE:NSPR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, dividends and media sentiment.

Conexeu Sciences has higher earnings, but lower revenue than InspireMD. Conexeu Sciences is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.11	N/A
InspireMD	$10.84M	3.30	-$19.92M	-$0.64	N/A

In the previous week, Conexeu Sciences had 4 more articles in the media than InspireMD. MarketBeat recorded 4 mentions for Conexeu Sciences and 0 mentions for InspireMD. InspireMD's average media sentiment score of 0.00 beat Conexeu Sciences' score of -0.51 indicating that InspireMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Conexeu Sciences	Negative
InspireMD	Neutral

44.8% of InspireMD shares are held by institutional investors. 25.0% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Conexeu Sciences presently has a consensus target price of $20.00, indicating a potential upside of 332.90%. InspireMD has a consensus target price of $4.50, indicating a potential upside of 484.42%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Conexeu Sciences has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Conexeu Sciences' return on equity of 0.00% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
InspireMD	-413.96%	-69.42%	-57.68%

Summary

InspireMD beats Conexeu Sciences on 8 of the 14 factors compared between the two stocks.

How does InspireMD compare to Apyx Medical?

InspireMD (NYSE:NSPR) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Apyx Medical has higher revenue and earnings than InspireMD. Apyx Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.84M	3.30	-$19.92M	-$0.64	N/A
Apyx Medical	$52.84M	2.40	-$11.21M	-$0.20	N/A

InspireMD has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.31, suggesting that its stock price is 31% more volatile than the broader market.

InspireMD presently has a consensus target price of $4.50, suggesting a potential upside of 484.42%. Apyx Medical has a consensus target price of $6.60, suggesting a potential upside of 119.27%. Given InspireMD's stronger consensus rating and higher possible upside, equities analysts clearly believe InspireMD is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

Apyx Medical has a net margin of -14.78% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Apyx Medical	-14.78%	-76.60%	-13.91%

44.8% of InspireMD shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 25.0% of InspireMD shares are held by company insiders. Comparatively, 15.9% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Apyx Medical had 3 more articles in the media than InspireMD. MarketBeat recorded 3 mentions for Apyx Medical and 0 mentions for InspireMD. Apyx Medical's average media sentiment score of 1.33 beat InspireMD's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
InspireMD	Neutral
Apyx Medical	Positive

Summary

Apyx Medical beats InspireMD on 11 of the 17 factors compared between the two stocks.

Get InspireMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NSPR vs. The Competition

Export

Metric	InspireMD	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$35.80M	$5.49B	$7.19B	$22.93B
Dividend Yield	N/A	1.79%	2.57%	3.58%
P/E Ratio	-1.03	25.26	274.09	28.24
Price / Sales	3.30	68.32	697.83	18.99
Price / Cash	N/A	32.78	77.71	34.34
Price / Book	0.42	5.96	10.37	4.66
Net Income	-$19.92M	$151.55M	$3.49B	$1.07B
7 Day Performance	-2.53%	-1.60%	-1.78%	-2.12%
1 Month Performance	-21.62%	-4.12%	-1.48%	-4.92%
1 Year Performance	-68.05%	8.63%	18.20%	8.27%

InspireMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NSPR InspireMD	1.9248 of 5 stars	$0.77 flat	$4.50 +484.4%	-67.6%	$35.80M	$10.84M	N/A	50
KRMD KORU Medical Systems	3.9506 of 5 stars	$3.17 -2.5%	$7.00 +120.8%	-19.8%	$149.28M	$41.13M	N/A	80	Positive News Analyst Upgrade
OWLT Owlet	2.6134 of 5 stars	$4.97 -0.2%	$15.00 +201.8%	-32.8%	$145.53M	$114.41M	N/A	106
INGN Inogen	0.8379 of 5 stars	$5.23 -3.5%	N/A	-39.3%	$143.84M	$348.67M	N/A	1,030	Positive News
CNXU Conexeu Sciences	2.5722 of 5 stars	$4.68 -5.8%	$20.00 +327.4%	N/A	$132.99M	N/A	N/A	4	Earnings Report Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NSPR) was last updated on 9/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InspireMD (NSPR) Competitors

NSPR vs. KRMD, OWLT, INGN, CNXU, and APYX

How does InspireMD compare to KORU Medical Systems?

Summary

How does InspireMD compare to Owlet?

Summary

How does InspireMD compare to Inogen?

Summary

How does InspireMD compare to Conexeu Sciences?

Summary

How does InspireMD compare to Apyx Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NSPR vs. The Competition

InspireMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InspireMD (NSPR) Competitors

NSPR vs. KRMD, OWLT, INGN, CNXU, and APYX

How does InspireMD compare to KORU Medical Systems?

Is KRMD or NSPR more profitable?

Which has preferable valuation and earnings, KRMD or NSPR?

Does the media prefer KRMD or NSPR?

Which has more volatility and risk, KRMD or NSPR?

Do insiders & institutionals hold more shares of KRMD or NSPR?

Do analysts prefer KRMD or NSPR?

Summary

How does InspireMD compare to Owlet?

Do analysts prefer NSPR or OWLT?

Is NSPR or OWLT more profitable?

Do insiders and institutionals believe in NSPR or OWLT?

Which has more volatility & risk, NSPR or OWLT?

Which has preferable earnings and valuation, NSPR or OWLT?

Does the media refer more to NSPR or OWLT?

Summary

How does InspireMD compare to Inogen?

Which has stronger earnings & valuation, NSPR or INGN?

Is NSPR or INGN more profitable?

Do insiders and institutionals hold more shares of NSPR or INGN?

Which has more risk & volatility, NSPR or INGN?

Do analysts prefer NSPR or INGN?

Does the media favor NSPR or INGN?

Summary

How does InspireMD compare to Conexeu Sciences?

Which has stronger earnings and valuation, CNXU or NSPR?

Does the media favor CNXU or NSPR?

Do insiders & institutionals hold more shares of CNXU or NSPR?

Do analysts recommend CNXU or NSPR?

Is CNXU or NSPR more profitable?

Summary

How does InspireMD compare to Apyx Medical?

Which has higher valuation and earnings, NSPR or APYX?

Which has more risk and volatility, NSPR or APYX?

Do analysts rate NSPR or APYX?

Is NSPR or APYX more profitable?

Do insiders & institutionals have more ownership in NSPR or APYX?

Does the media favor NSPR or APYX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NSPR vs. The Competition

InspireMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools